Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John A. Jernigan

Showing results (1-10 of 146) with videos related to

Pageof 15
Sort By:
Current Infectious Disease Reports|November 13, 2004
Eradicating Nasal Carriage of Staphylococcus aureus As a Strategy for Preventing Health Care-associated Infections in Nonsurgical PatientsJohn A Jernigan
Infection Control and Hospital Epidemiology|July 10, 2004
Is the burden of Staphylococcus aureus among patients with surgical-site infections growing?John A Jernigan
Annals of Emergency Medicine|October 31, 2008
Methicillin-resistant Staphylococcus aureus colonization among health care personnel in the emergency department: what does it tell us?John A Jernigan
Current Infectious Disease Reports|October 18, 2005
Aiming for zero: is complete elimination of catheter-related bloodstream infections among intensive care unit patients a realistic goal?John A Jernigan
Current Infectious Disease Reports|November 28, 2001
Clinical Trials ReportJohn A. Jernigan
Current Infectious Disease Reports|November 16, 2002
Control of vancomycin-resistant Enterococcus in Healthcare facilities in a regionJohn A. Jernigan
The Journal of Infectious Diseases|January 19, 2005
Impact of vancomycin resistance on mortality among patients with neutropenia and enterococcal bloodstream infectionCarlos A DiazGranados, John A Jernigan
Infectious Disease Clinics of North America|January 13, 2009
Staphylococcal Infections. PrefaceRachel J Gorwitz, John A Jernigan
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 1, 2006
Reply to Nannini and to a previous letter by HurleyCarlos A DiazGranados, John A Jernigan
Journal of Hospital Medicine|February 28, 2019
Things We Do For Good Reasons: Contact Precautions for Multidrug-resistant Organisms, Including MRSA and VRELisa L Maragakis, John A Jernigan
Pageof 15

Showing results (1-10 of 146) with videos related to

Sort By:
Pageof 15
Current Infectious Disease Reports|November 13, 2004
Eradicating Nasal Carriage of Staphylococcus aureus As a Strategy for Preventing Health Care-associated Infections in Nonsurgical PatientsJohn A Jernigan
Infection Control and Hospital Epidemiology|July 10, 2004
Is the burden of Staphylococcus aureus among patients with surgical-site infections growing?John A Jernigan
Annals of Emergency Medicine|October 31, 2008
Methicillin-resistant Staphylococcus aureus colonization among health care personnel in the emergency department: what does it tell us?John A Jernigan
Current Infectious Disease Reports|October 18, 2005
Aiming for zero: is complete elimination of catheter-related bloodstream infections among intensive care unit patients a realistic goal?John A Jernigan
Current Infectious Disease Reports|November 28, 2001
Clinical Trials ReportJohn A. Jernigan
Current Infectious Disease Reports|November 16, 2002
Control of vancomycin-resistant Enterococcus in Healthcare facilities in a regionJohn A. Jernigan
The Journal of Infectious Diseases|January 19, 2005
Impact of vancomycin resistance on mortality among patients with neutropenia and enterococcal bloodstream infectionCarlos A DiazGranados, John A Jernigan
Infectious Disease Clinics of North America|January 13, 2009
Staphylococcal Infections. PrefaceRachel J Gorwitz, John A Jernigan
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 1, 2006
Reply to Nannini and to a previous letter by HurleyCarlos A DiazGranados, John A Jernigan
Journal of Hospital Medicine|February 28, 2019
Things We Do For Good Reasons: Contact Precautions for Multidrug-resistant Organisms, Including MRSA and VRELisa L Maragakis, John A Jernigan
Pageof 15